PRICE T ROWE ASSOCIATES INC /MD/ - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 124 filers reported holding CARDLYTICS INC in Q4 2022. The put-call ratio across all filers is 1.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$378
+98.9%
22,907
-23.6%
0.00%
Q2 2023$190
+91.9%
29,982
+3.5%
0.00%
Q1 2023$99
-23.3%
28,977
+29.5%
0.00%
Q4 2022$129
-99.9%
22,377
-1.6%
0.00%
Q3 2022$214,000
-45.4%
22,750
+29.4%
0.00%
Q2 2022$392,000
-56.5%
17,580
+7.2%
0.00%
Q1 2022$901,000
-10.9%
16,396
+7.1%
0.00%
Q4 2021$1,011,000
-23.6%
15,304
-2.9%
0.00%
Q3 2021$1,324,000
-29.6%
15,768
+6.4%
0.00%
Q2 2021$1,881,000
+12.5%
14,823
-2.8%
0.00%
Q1 2021$1,672,000
-7.9%
15,246
+19.9%
0.00%
Q4 2020$1,816,000
+173.1%
12,718
+35.0%
0.00%
Q3 2020$665,000
-11.2%
9,419
-12.0%
0.00%
Q2 2020$749,000
-32.8%
10,698
-84.1%
0.00%
Q1 2019$1,114,000
+167.1%
67,379
+74.9%
0.00%
Q4 2018$417,000
-91.3%
38,533
-80.0%
0.00%
-100.0%
Q3 2018$4,817,000192,3800.00%
Other shareholders
CARDLYTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Canaan Partners VIII LLC 1,133,141$29,439,00058.62%
Polaris Venture Management Co. V, L.L.C. 2,277,342$59,165,00046.48%
CAS Investment Partners, LLC 2,162,020$56,169,00014.39%
Cannell Capital 626,975$16,289,0004.62%
Antipodean Advisors LLC 142,358$3,698,0004.50%
Shannon River Fund Management LLC 344,230$8,943,0001.42%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 19,048$495,0001.40%
Tygh Capital Management, Inc. 176,237$4,579,0000.78%
Penn Capital Management Company, LLC 263,499$6,846,0000.68%
EAM Global Investors LLC 56,866$1,477,0000.63%
View complete list of CARDLYTICS INC shareholders